Immune responses against SARS-CoV-2 variants after two and three doses of vaccine in B-cell malignancies: UK PROSECO study

Patients with hematological malignancies are at increased risk of severe COVID-19 outcomes due to compromised immune responses, but the insights of these studies have been compromised due to intrinsic limitations in study design. Here we present the PROSECO prospective observational study (NCT048585...

Descripción completa

Detalles Bibliográficos
Autores principales: Lim, Sean H., Stuart, Beth, Joseph-Pietras, Debora, Johnson, Marina, Campbell, Nicola, Kelly, Adam, Jeffrey, Danielle, Turaj, Anna H., Rolfvondenbaumen, Kate, Galloway, Celine, Wynn, Thomas, Coleman, Adam R., Ward, Benjamin, Long, Karen, Coleman, Helen, Mundy, Carina, Bates, Andrew T., Ayres, Diana, Lown, Robert, Falconer, Janlyn, Brake, Oliver, Batchelor, James, Willimott, Victoria, Bowzyk Al-Naeeb, Anna, Robinson, Lisa, O’Callaghan, Ann, Collins, Graham P., Menne, Tobias, Faust, Saul N., Fox, Christopher P., Ahearne, Matthew, Johnson, Peter W. M., Davies, Andrew J., Goldblatt, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135622/
https://www.ncbi.nlm.nih.gov/pubmed/35332334
http://dx.doi.org/10.1038/s43018-022-00364-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135622/
https://www.ncbi.nlm.nih.gov/pubmed/35332334
http://dx.doi.org/10.1038/s43018-022-00364-3

Ejemplares similares